The Leukemia & Lymphoma Society (LLS) advocates public policy positions that accelerate progress toward cures for leukemia, Hodgkin and non-Hodgkin lymphoma and myeloma.
The aim of LLS's advocacy program is to improve the quality of life of those with blood cancer, their friends and families. The following links will provide information on LLS's legislative priorities aimed at accomplishing that goal.The First Session of the 111th Congress Legislative Agenda for The Leukemia & Lymphoma SocietyDepartment of Defense (DoD) Blood Cancer Research Program
Increase Cancer Research Funding at the National Institutes of Health (NIH) and National Cancer Institute (NCI)Access to Clinical TrialsPediatric Cancer Survivorship LegislationComprehensive Cancer Care FundingKennedy-Hutchison Cancer BillHealth Care ReformIssue Briefs
